Manipal Health Soars to 11% Premium on Market Debut.

On Wednesday, Manipal Health Enterprises made a notable market debut, with shares listed at a premium of up to 11% over the initial public offer (IPO) price of ₹590. The stock opened at ₹652 on the National Stock Exchange (NSE) and slightly higher at ₹655 on the Bombay Stock Exchange (BSE). During the trading session, the shares reached intraday highs of ₹675.80 on the NSE and ₹676.05 on the BSE, before ultimately closing at ₹663.15 and ₹666.70, respectively. This performance underscores strong investor interest in the healthcare sector, propelled by an increased focus on health infrastructure in the post-pandemic landscape.

The company’s market capitalization at the close of trading was recorded at ₹87,229.24 crore, contrasting with its higher estimated market value of ₹128,112 crore on the preceding Tuesday. This indicates substantial investor confidence, especially given that the IPO was substantially oversubscribed, achieving a subscription rate of 4.92 times. Such demand reflects the strategic positioning of Manipal Health as one of India’s largest hospital chains, effectively capturing market sentiment favorable to healthcare investments.

The ₹9,275-crore IPO was structured with a fresh issuance of shares worth ₹8,000 crore and included an offer for sale (OFS) of 2.16 crore equity shares totaling ₹1,275.2 crore. This IPO ranks as the second-largest of the year, following SBI Funds Management’s substantial ₹9,795-crore issue, which was remarkably oversubscribed at a rate of 41.73 times. The solid backing by Temasek and the well-defined price band of ₹560-590 per share contributed to the robust market response, with the healthcare sector continuing to attract significant capital inflows amidst evolving health needs and demographic trends.

Source: The Economic Times

(Expert Note: This report was prepared by the Wealthova team.)